TrialMedicine2018

Rapamycin treatment for amyotrophic lateral sclerosis: Protocol for a phase II randomized, double-blind, placebo-controlled, multicenter, clinical trial (RAP-ALS trial).

Jessica Mandrioli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.